MedPath

Fondazione Epatocentro Ticino

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:2

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease

Recruiting
Conditions
NAFLD
MASH
NASH/MASH
First Posted Date
2025-07-04
Last Posted Date
2025-07-09
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
200
Registration Number
NCT07051863
Locations
🇨🇭

Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland

Methylene Blue Treatment of Chronic Hepatitis B Virus Infection

Phase 2
Recruiting
Conditions
Chronic HBV Infection
Interventions
First Posted Date
2025-03-20
Last Posted Date
2025-08-17
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
10
Registration Number
NCT06887036
Locations
🇨🇭

Epatocentro Ticino, Lugano, Ticino, Switzerland

Methylene Blue Treatment of COVID-19

Phase 2
Completed
Conditions
SARS-CoV2
Interventions
Drug: Control Test
First Posted Date
2020-11-19
Last Posted Date
2025-08-17
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
29
Registration Number
NCT04635605
Locations
🇨🇭

Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland

Swiss Primary Sclerosing Cholangitis Cohort Study

Recruiting
Conditions
Cholangitis, Sclerosing
PSC
Primary Sclerosing Cholangitis (PSC)
First Posted Date
2017-05-10
Last Posted Date
2025-08-19
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
120
Registration Number
NCT03146936
Locations
🇨🇭

Spital Bülach, Bülach, Switzerland

🇨🇭

Kantonsspital Graubünden, Chur, Switzerland

🇨🇭

CHUV: Centre hospitalier universitaire vaudois, Lausanne, Switzerland

and more 18 locations

Swiss Primary Biliary Cholangitis Cohort Study

Recruiting
Conditions
PBC
Primary Biliary Cholangitis
First Posted Date
2017-05-10
Last Posted Date
2025-08-17
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
500
Registration Number
NCT03146910
Locations
🇨🇭

Spital Bülach, Bülach, Switzerland

🇨🇭

Kantonsspital Graubünden, Chur, Switzerland

🇨🇭

CHUV: Centre hospitalier universitaire vaudois, Lausanne, Switzerland

and more 10 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.